$9.5M to Leidos
COVID ACTIV3 TASK ORDER SUPPORTS NIAID'S GOAL TO BETTER UNDERSTAND THE CORONAVIRUS WITH AN INITIAL FOCUS ON ACTIV3. THIS TASK ORDER WILL INITIATE THE MANAGEMENT , OVERSIGHT , AND CONDUCT OF THE NIAID DCR CLINICAL TRIAL TITLED A MULTICENTER, ADA
- Company
- LDOSLeidos
- Recipient name in record
- LEIDOS BIOMEDICAL RESEARCH INC
- Awarded by
- Department of Health and Human Services · National Institutes of Health
- Value
- $9.5M
- Start date
- 30 Jun 2020
- End date
- 12 Jun 2026
- Award ID
- 75N91020F00014
- Source
- View official record on USAspending.gov ↗
The match between the recipient name and the listed company is made by StockRoz and can contain errors.